ALLR
ALLR
NASDAQ · Biotechnology

Allarity Therapeutics Inc

$0.97
-0.06 (-5.98%)
As of Sep 28, 10:39 PM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +3,264.3% upside
Low Target $17.80
Average Target $32.58
High Target $40.39
Current Price $0.97
Current
$0.97
Target
$32.58
$17.80 $32.58 avg $40.39
Scenario Analysis
Bear Case
$17.80
1,738.1%
Low target
Base Case
$32.58
+3,264.3%
Avg target
Bull Case
$40.39
+4,070.8%
High target
Risk/Reward
2.3x
Favorable
Price in Context
52-Week High
$1.84
-47.4% from high
52-Week Low
$0.77
+25.9% from low
Target vs 52W High
$32.58
+1,671.1% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -3.3%
AMGN
Amgen Inc
Hold 43 47% $190.87 -54.4%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +138.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -16.9%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -89.8%
MRNA
Moderna Inc
Hold 30 37% $149.45 -24.2%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -65.3%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -43.4%